论文部分内容阅读
选择性颈淋巴廓清(END)是用来处理头颈部恶性肿瘤中颈部有高危转移的患者。但长期以来对此一直有争论。为了更合理的行END,使END有可循的客观指标,作者对182例头颈部鳞癌术前临床、CT和MRI检查和行根治性和改良性颈廓清术后标本病检结果作回顾性比较分析。182例中有150例术前行CT检查。32例行END检查,以上检查均在术前1月内进行。每一患者颈部淋巴结均经仔细的临床检查,无论是CT或MRI扫描显示淋巴结中心坏死、血管受侵犯、脂肪平面消失,或淋巴结大于1cm者应考虑为淋巴结异常。上述扫描结
Selective cervical lymph node clearance (END) is used to treat patients with high-risk neck metastases in head and neck malignancies. But there has been a long debate about this. In order to make the END more reasonable and to allow the END to follow the objective indicators, the authors reviewed the results of preoperative clinical, CT and MRI examinations of 182 cases of head and neck squamous cell carcinoma and the results of pathological examination of specimens after radical and modified neck dissection Comparative analysis of sex. There were 150 cases of preoperative CT in 182 cases. 32 cases of END examination, the above examination were conducted within 1 month before surgery. Cervical lymph nodes in each patient undergo a careful clinical examination, either CT or MRI scan showed necrosis of the center of the lymph nodes, vascular invasion, disappearance of fat plane, or lymph nodes greater than 1cm should be considered as lymph node abnormalities. The above scan junction